688161 威高骨科
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)4.2222.53112.59719.76525.819
总资产报酬率 ROA (%)3.2492.02110.52116.09517.485
投入资产回报率 ROIC (%)3.9852.40712.20319.09424.960

边际利润分析
销售毛利率 (%)64.66766.52276.57781.17482.359
营业利润率 (%)18.51910.19834.33037.68136.554
息税前利润/营业总收入 (%)17.2268.22832.45436.73735.827
净利润/营业总收入 (%)15.5488.81129.17232.10230.800

收益指标分析
经营活动净收益/利润总额(%)86.93383.05896.46297.177102.279
价值变动净收益/利润总额(%)9.86821.1333.9032.8130.000
营业外收支净额/利润总额(%)-0.2760.556-0.042-0.191-0.096

偿债能力分析
流动比率 (X)4.3843.9245.9056.4054.173
速动比率 (X)3.6163.2315.1555.6353.264
资产负债率 (%)21.80523.98616.78316.02122.379
带息债务/全部投入资本 (%)1.2323.5980.9570.1230.312
股东权益/带息债务 (%)7,766.6152,588.71110,105.75778,606.12930,677.632
股东权益/负债合计 (%)357.761316.487495.813523.489345.391
利息保障倍数 (X)-13.869-4.059-17.434-42.121-51.757

营运能力分析
应收账款周转天数 (天)67.967115.56675.76255.86064.761
存货周转天数 (天)528.114594.996459.860497.492546.349